drugset / Trial / NCT02373098
Fingolimod Effect on Cytokine and Chemokine Levels
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The main purpose of this study was to measure the serum levels of cytokines and chemokines that are known to increase during multiple sclerosis relapses. Cytokines are a broad and loose category of small proteins that are important in cell signaling. The second purpose of the study was to test the cytokine/chemokine changes measured in the 3rd and 6th months on the efficacy parameters.
Timeline
- Start
- 2015-03-31
- Primary completion
- 2017-01-18
- Completion
- 2017-01-18
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Fingolimod | Small molecule | 0.5 mg | — |